secwatch / observer
8-K filed May 7, 2024, 7:59 PM ET CIK 0001365916
other material confidence high sentiment negative materiality 1.00

AMYRIS, INC.: debt financing — Amyris emerges from Chapter 11; all existing shares cancelled

AMYRIS, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Doerr

director
AMYRIS, INC.
Effective
2024-05-07
Filed
May 7, 2024, 7:59 PM ET
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.
Appointed

Ryan Panchadsaram

director
AMYRIS, INC.
Effective
2024-05-07
Filed
May 7, 2024, 7:59 PM ET
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

AMYRIS, INC. incurred credit facility of $160 million with Euagore, LLC.

Instrument
credit facility
Principal
$160 million
Counterparty
Euagore, LLC
Event
incurrence
Exact text from the filing
the Lenders agreed to make available to the Borrowers loans in an aggregate principal amount of up to $160 million, excluding the $30 million principal portion of the Company’s outstanding DIP Facility that is amended and restated, rolled-over into and assumed as part of the Exit First Lien Facility.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Doerr was appointed as director at AMYRIS, INC..

Action
became
Role
director
Exact text from the filing
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Panchadsaram was appointed as director at AMYRIS, INC..

Action
became
Role
director
Exact text from the filing
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

AMYRIS, INC. entered into Amended and Restated Loan Agreement (Exit First Lien Facility) with Euagore, LLC valued at up to $160 million aggregate principal amount (effective 2024-05-07).

Action
entry
Agreement
credit facility
Counterparty
Euagore, LLC
Value
up to $160 million aggregate principal amount
Effective
2024-05-07
Exact text from the filing
the Company, AB Technologies LLC, and Aprinnova, LLC (collectively, the “ Borrowers ”), and certain other subsidiaries of the Company (the “ Guarantors ”) entered into an Amended and Restated Loan Agreement (the “ Exit First Lien Facility ”), dated as of the Effective Date (as amended, restated, supplemented or otherwise modified from time to time), by and among the Borrowers, Guarantors, each lender from time to time party thereto (the “ Lenders ”) and Euagore, LLC, an affiliate of Foris Ventures LLC, in its capacity as administrative agent.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AMYRIS, INC. terminated DIP Credit Agreement with Euagore, LLC valued at DIP Credit Agreement was amended and restated as part of the Exit First Lien Facility, outstanding p (effective 2024-05-07).

Action
termination
Agreement
credit facility
Counterparty
Euagore, LLC
Value
DIP Credit Agreement was amended and restated as part of the Exit First Lien Facility, outstanding p
Effective
2024-05-07
Exact text from the filing
On the Effective Date, (x) the DIP Credit Agreement was amended and restated as part of the Exit First Lien Facility described below such that the outstanding principal amount due on the DIP Facility was reduced to $30 million and (y) $20 million of the DIP Facility Claims were converted into 100% of the New Common Stock of Reorganized Amyris.
View on SEC.gov

311 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR
accession 0001193125-24-132953
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.